Sitemap

October 23, 2004 Articles

Filter by Available Specialty
  1. Carl Zeiss Meditec to buy LDT
  2. Gene therapy, stem cells show promise for AMD in early studies
  3. LASIK still most common refractive surgical procedure, survey finds
  4. Macugen effects sustained for 2 years in AMD study